Literature DB >> 15526966

Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects.

Raman Sankar1, Gregory L Holmes.   

Abstract

Antiepileptic drugs exert their anticonvulsant effects by interfering with brain processes that involve structures that are also involved in learning, memory, and emotional behavior. Thus, modulation of ion channels, neurotransmitters, second messengers, and other processes by antiepileptic drugs, although helpful in controlling seizures, can interfere with normal brain function in undesired ways. The specific mechanism(s) of action of an antiepileptic drug can increase the risk for particular types of adverse events. In this review, we examine the cognitive and behavioral effects of antiepileptic drugs in animal models. Although animal studies, in many respects, do not mimic clinical experience, the data suggest a connection between certain mechanisms of antiepileptic action and the occurrence of cognitive adverse effects. Specifically, antiepileptic drugs with traditional gamma-aminobutyric acid (GABA)ergic mechanisms have the most detrimental effects on cognitive function, possibly because they impair attention. Conversely, drugs with the predominant effects at Na+ channels appear to have minimal impact on cognition. Levetiracetam, with its nonconventional GABAergic and Ca2+ channel effects, has shown positive cognitive effects in animal studies. Antiglutamatergic drugs have the potential to be a double-edged sword: they can interfere with consolidation of learning and memory but can also provide neuroprotection in addition to their antiseizure effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526966     DOI: 10.1177/088307380401900102

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  8 in total

1.  Galanin and epilepsy: promises with nuances...

Authors:  Raman Sankar
Journal:  Epilepsy Curr       Date:  2005 Mar-Apr       Impact factor: 7.500

2.  Age-dependent effects of topiramate on the acquisition and the retention of rapid kindling.

Authors:  Andréy Mazarati; Don Shin; Stéphane Auvin; Raman Sankar
Journal:  Epilepsia       Date:  2007-02-23       Impact factor: 5.864

Review 3.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

Review 4.  Mitochondria, oxidative stress, and temporal lobe epilepsy.

Authors:  Simon Waldbaum; Manisha Patel
Journal:  Epilepsy Res       Date:  2009-10-21       Impact factor: 3.045

Review 5.  The 2008 Judith Hoyer lecture: epilepsy in children: listening to mothers.

Authors:  Gregory L Holmes
Journal:  Epilepsy Behav       Date:  2009-08-31       Impact factor: 2.937

Review 6.  Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.

Authors:  Jennifer Leigh Green; Wagner Ferreira Dos Santos; Andréia Cristina Karklin Fontana
Journal:  Biochem Pharmacol       Date:  2021-09-24       Impact factor: 5.858

7.  Clinical considerations in transitioning patients with epilepsy from clonazepam to clobazam: a case series.

Authors:  Raman Sankar; Steve Chung; Michael Scott Perry; Ruben Kuzniecky; Saurabh Sinha
Journal:  J Med Case Rep       Date:  2014-12-16

8.  Dampening of hyperexcitability in CA1 pyramidal neurons by polyunsaturated fatty acids acting on voltage-gated ion channels.

Authors:  Jenny Tigerholm; Sara I Börjesson; Linnea Lundberg; Fredrik Elinder; Erik Fransén
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.